NCT03969381

Brief Summary

  • The goal of this study is to determine the feasibility of the diffusion weighted Magnetic Resonance Imaging in the evaluation of the treatment response in patients with malignant lymphoma.
  • The investigator's objective is to compare the changes of mean Apparent Diffusion Coefficient value of the tumor with the changes of maximum Standardized Uptake Value of the tumor in positron Emission Tomography Computed Tomography in both pre and post therapy status .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 31, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

May 31, 2019

Status Verified

May 1, 2019

Enrollment Period

2.3 years

First QC Date

May 23, 2019

Last Update Submit

May 30, 2019

Conditions

Lymphoma

Outcome Measures

Primary Outcomes (1)

  • role of diffusion weighted imaging in followup of lymphoma

    • measures mean Apparent diffusion coefficient value in pre and post therapy status in patients with lymphoma with cut off value 1 .

    5 minutes

Study Arms (1)

1 lymphoma patients

pre therapy and post therapy of lymphoma patients

Radiation: diffusion weighted magnetic resonance image in lymphoma

Interventions

diffusion weighted magnetic resonance image in lymphomaRADIATION

compare between result of positron emission tomography /computed tomography and diffusion weighted imaging in followup of lymphoma

1 lymphoma patients

Eligibility Criteria

Age8 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients diagnosed as malignant lymphoma

You may qualify if:

  • patients clinically diagnosed as lymphoma patient can tolerate the magnetic resonance examination.

You may not qualify if:

  • presence of paramagnetic substance as peace maker or cochlear implants and claustrophobia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lymphoma

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • sara, Msc

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abouzeid Hazem, professor

CONTACT

01005075888sarad423@yahoo.com

Khodary Omran, lecturer

CONTACT

omranshow@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principel investigator

Study Record Dates

First Submitted

May 23, 2019

First Posted

May 31, 2019

Study Start

September 1, 2019

Primary Completion

December 30, 2021

Study Completion

January 30, 2022

Last Updated

May 31, 2019

Record last verified: 2019-05